Recent studies have implicated PSMC4 in various cancers, including breast cancer (10), endometrial cancer (11, 12), prostate carcinoma (13, 14), and oral squamous cell carcinoma (15), where its dysregulation contributes to tumorigenesis and cancer progression. Here, PSMC4 is linked to cancer.